LifeStance Health Group, Inc.
General ticker "LFST" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $2.4B (TTM average)
LifeStance Health Group, Inc. follows the US Stock Market performance with the rate: 2.9%.
Estimated limits based on current volatility of 1.9%: low 7.20$, high 7.48$
Factors to consider:
- Total employees count: 10218 (+9.6%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Government regulations, Strategic risks and growth management, Clinician recruitment/retention, Market competition, Leadership changes
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.53$, 10.55$]
- 2025-12-31 to 2026-12-31 estimated range: [6.57$, 10.66$]
Financial Metrics affecting the LFST estimates:
- Negative: with PPE of -45.6 at the end of fiscal year the price was high
- Positive: -5.02 < Operating profit margin, % of -2.46
- Positive: -3.57 < Return on assets ratio (scaled to [-100,100]) of -2.64
- Positive: -9.48 < Industry operating profit margin (median), % of -2.81
- Positive: Shareholder equity ratio, % of 68.28 > 64.17
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: -0.04 < Industry operating cash flow per share per price (median), % of 3.20
Short-term LFST quotes
Long-term LFST plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $859.54MM | $1,055.66MM | $1,250.97MM |
| Operating Expenses | $1,069.72MM | $1,244.80MM | $1,282.58MM |
| Operating Income | $-210.17MM | $-189.13MM | $-31.61MM |
| Non-Operating Income | $-22.56MM | $-17.45MM | $-26.00MM |
| Interest Expense | $19.93MM | $21.22MM | $26.54MM |
| Income(Loss) | $-232.73MM | $-206.58MM | $-57.61MM |
| Taxes | $-17.17MM | $-20.32MM | $-0.17MM |
| Profit(Loss)* | $-215.56MM | $-186.26MM | $-57.44MM |
| Stockholders Equity | $1,518.72MM | $1,428.93MM | $1,446.29MM |
| Assets | $2,173.87MM | $2,109.97MM | $2,118.30MM |
| Operating Cash Flow | $52.79MM | $-16.88MM | $107.26MM |
| Capital expenditure | $79.25MM | $40.52MM | $21.57MM |
| Investing Cash Flow | $-139.46MM | $-60.34MM | $-21.57MM |
| Financing Cash Flow | $47.26MM | $47.43MM | $-9.95MM |
| Earnings Per Share** | $-0.61 | $-0.51 | $-0.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.